Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:

NCT ID: NCT05271357 Completed - Clinical trials for Major Depressive Disorder

Transcranial Magnetic Stimulation for Depression in Autism Spectrum Conditions

RESTORE
Start date: November 24, 2021
Phase: N/A
Study type: Interventional

In this research study the investigators aim to learn more about the therapeutic effects of a newer form of non-invasive transcranial magnetic stimulation (TMS), called theta burst simulation (TBS), on refractory depression in Autism Spectrum Conditions.

NCT ID: NCT05256095 Completed - Clinical trials for Autism Spectrum Disorder

Thinking in Speech for Children With Autism

Start date: May 12, 2021
Phase: N/A
Study type: Interventional

This study examines a cognitive therapy for autistic children, Thinking in Speech. Thinking in Speech helps children with autism independently cope with everyday events that cause stress, by developing their ability to use "inner speech".

NCT ID: NCT05254769 Recruiting - Clinical trials for Autism Spectrum Disorder

Neurofeedback Intervention in Children With Autism Spectrum Disorder (ASD)

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

This project aims to: - explore the effectiveness of Neurofeedback therapy for children diagnosed with Autism Spectrum Disorder (ASD) - assess if cognitive functions are affected before and after Neurofeedback Intervention

NCT ID: NCT05236803 Recruiting - Clinical trials for Autism Spectrum Disorder

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

MOTRICITE TSA
Start date: February 7, 2022
Phase: N/A
Study type: Interventional

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

NCT ID: NCT05235919 Recruiting - Clinical trials for Autism Spectrum Disorder

Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder

Start date: September 22, 2022
Phase: Phase 2
Study type: Interventional

This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.

NCT ID: NCT05223374 Completed - Clinical trials for Children18-72 Months With a Suspicion Autistic Disorder

Extension for Community Healthcare Outcomes (ECHO) Autism Diagnostic Study in Primary Care Setting

Start date: March 1, 2022
Phase:
Study type: Observational

This is a collaborative study that will provide a comprehensive source of observational data that can be used to obtain real world evidence of ASD. The study will contain demographic and observational clinical data for eligible participants. All decisions regarding patient care will be determined by the ECHO Autism Clinician (EAC). All clinical outcomes will be assessed by the EAC as would occur in routine clinical practice.

NCT ID: NCT05213286 Recruiting - Clinical trials for Autism Spectrum Disorder

The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R

ZA-RAA
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the validity, reliability and clinical features of a Danish version of the Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R). A self-reporting scale devise used as a supplementary questionnaire in diagnosing autism spectrum disorder (ASD) in adults. Furthermore the validity of novel screening questionnaire: SchiZotypal Autism Questionnaire (ZAQ), will be investigated. ZAQ is developed to discriminate Schizotypal Disorder from ASD.

NCT ID: NCT05208411 Recruiting - Clinical trials for Autism Spectrum Disorder

Prodromal ImPACT Intervention for Children at Elevated Likelihood of ASD

SAPIENS
Start date: March 28, 2022
Phase: N/A
Study type: Interventional

This randomised-controlled trial will assess the effect of an early intervention on the social-communicative abilities and brain activity of infants with elevated likelihood of Autism Spectrum Disorder (ASD). The children´s social-communicative abilities and the related brain activity will be evaluated at three time points: before the start of the intervention (pre-intervention), immediately after its conclusion (post-intervention) and 6 months after its conclusion (follow-up).

NCT ID: NCT05200351 Recruiting - Clinical trials for Autism Spectrum Disorder

Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design

Start date: February 14, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the (cost)effectivity of Equine assisted Therapy in adolescents with Autism Spectrum disorders.

NCT ID: NCT05197634 Completed - COVID-19 Pandemic Clinical Trials

The Impact of Covid-19 Pandemic On The Children With Autism Spectrum Disorder

Start date: September 6, 2021
Phase:
Study type: Observational

The Covid-19 outbreak has caused families and individuals to change their life routines and eating habits, and has affected their psychology, especially for children with autism, due to the change in their routines. These psychological changes may trigger the self-harming behavior that is very common in children with autism. Dental trauma, a common problem in children and adolescents, can also be seen in individuals who need special care such as autism. The aim of this study is to evaluate the susceptibility of children with autism to orofacial trauma during the pandemic period and compare them with the pre-pandemic period and the healthy group, as well as to question the lifestyle, nutritional habits, mood changes and oral health behaviors that may be related to the risk of trauma.